Preston Klassen
Overview
Preston Klassen received $5M in total compensation, including $112K in salary, at Zura Bio Ltd in 2023. Preston Klassen also received an average of $6M at Metacrine between 2020 and 2021 and an average of $1M at Orexigen Therapeutics from 2009 to 2015.
- 2023
- 2021
- 2020
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
Zura Bio LtdFormer President and Chief Operating Officer
MetacrinePresident and Chief Executive Officer
MetacrinePresident and Chief Executive Officer
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsExecutive Vice President, Global Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Executive Vice President, Product Development
Orexigen TherapeuticsHead of Global NB32 Program and Senior Vice President, Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Senior Vice President, Product Development
Orexigen TherapeuticsHead of Global Contrave Program and Senior Vice President, Product Development
Source: SEC filings on September 13, 2024, April 7, 2022, April 9, 2021, May 27, 2016, April 22, 2015, April 30, 2014, April 23, 2013, and April 27, 2012.
Related executives
We found 22 more executives who work or worked at Zura Bio Ltd, Metacrine, andOrexigen Therapeutics.
Someit Sidhu
Zura Bio Ltd
Chief Executive Officer
Kim Davis
Zura Bio Ltd
Chief Legal Officer
Chris Cabell
Zura Bio Ltd
Chief Medical Officer
Verender Badial
Zura Bio Ltd
Chief Financial Officer
Michael Howell
Zura Bio Ltd
Chief Scientific Officer
Patricia Millican
Metacrine
Chief Financial Officer
Hubert Chen
Metacrine
Chief Medical Officer
Catherine Lee
Metacrine